🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,57 USD

Máx. histórico

178,74

2144 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,17%

Rango 52 semanas

14,68 – 24,68

Variación hoy

-7,48%

Cierre anterior

18,99

Rango de hoy

17,44 – 18,92

Volumen hoy

1.859.162

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 4 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
21/04/2022 81,07 81,40 75,87 77,35 -4,59% 6,82% 1.312.500
20/04/2022 81,87 81,96 80,15 81,07 -0,73% 2,21% 453.900
19/04/2022 80,27 83,58 80,02 81,67 +2,06% 4,44% 392.900
18/04/2022 81,25 81,25 79,47 80,02 -1,76% 2,19% 702.100
14/04/2022 83,39 83,56 81,28 81,45 -2,15% 2,73% 593.000
13/04/2022 82,03 84,45 81,90 83,24 +1,09% 3,11% 403.200
12/04/2022 84,28 85,62 81,78 82,34 -2,37% 4,56% 476.600
11/04/2022 87,50 87,68 83,79 84,34 -4,09% 4,45% 586.600
08/04/2022 87,90 89,55 86,51 87,94 -0,57% 3,46% 589.800
07/04/2022 87,81 89,21 86,38 88,44 +0,35% 3,22% 807.800
06/04/2022 85,79 89,44 85,02 88,13 +1,68% 5,15% 970.400
05/04/2022 85,82 88,25 85,37 86,67 +1,23% 3,36% 1.000.200
04/04/2022 83,50 86,06 83,42 85,62 +3,71% 3,16% 1.062.800
01/04/2022 78,42 82,67 78,39 82,56 +5,68% 5,46% 546.700
31/03/2022 78,99 79,70 77,99 78,12 -0,60% 2,16% 624.700
30/03/2022 78,65 79,32 77,25 78,59 -0,17% 2,63% 805.300
29/03/2022 76,50 79,29 76,40 78,72 +3,48% 3,78% 822.600
28/03/2022 77,25 77,77 74,18 76,07 -1,55% 4,65% 772.600
25/03/2022 80,25 80,37 76,96 77,27 -3,94% 4,25% 755.500
24/03/2022 80,77 81,38 79,50 80,44 +0,40% 2,33% 479.000
23/03/2022 81,80 82,38 79,74 80,12 -2,48% 3,23% 396.900
22/03/2022 81,13 82,69 80,55 82,16 +1,47% 2,64% 589.400
21/03/2022 81,82 82,50 79,57 80,97 -0,09% 3,58% 899.500
18/03/2022 78,92 81,45 78,62 81,04 +2,41% 3,59% 866.700
17/03/2022 75,63 79,76 75,63 79,13 +3,44% 5,46% 583.000
16/03/2022 77,57 77,57 73,57 76,50 +0,43% 5,16% 582.800
15/03/2022 74,68 76,36 74,26 76,17 +2,19% 2,81% 465.000
14/03/2022 78,15 79,20 73,01 74,54 -4,25% 7,92% 909.500
11/03/2022 82,61 82,86 77,60 77,85 -5,40% 6,37% 1.188.700
10/03/2022 83,25 83,75 81,02 82,29 -2,56% 3,28% 642.200